SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Kos Pharmaceuticals, Inc (KOSP)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom D who wrote (28)11/13/1997 8:31:00 AM
From: Jeff Briley  Read Replies (1) of 118
 
Tom,

If you read my entire post, that was exactly my point. Sure, earnings were obviously irrelevant because the stock tanked. I was just pointing out that they did beat estimates.

If they just started selling this drug in September, then there is no way to have any kind of feel for how it will do. That is why I think this Solomon guy who downgraded it "jumped the gun".

Frankly, I just bought it after the huge drop yesterday and I'm looking for a dead cat bounce in it today. Then I'll be on to bigger and better things.

Jeff
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News